Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. #lymphoma #lymsm https://t.co/u8ovvERdgm
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
Fascinating stuff https://t.co/h4oEmusmmE
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
#CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedicine https://t.co/3MUUxPyQOj | #Oct_ReCap https://t.co/SdaugljDD0
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
#CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedicine https://t.co/PveO1CDlf1 https://t.co/wxYsPCGYCC
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
RT @mmw_lmw: #CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedici…
#CAR_T_Cell_Therapy | Genetic mechanism of target antigen loss in CAR19 therapy of ALL | Elena Orlando @Novartis @NatureMedicine https://t.co/PveO1CDlf1 https://t.co/ZE8100zwdC
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
Oh wow 👏🏼
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
RT @NatureMedicine: Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of ana…
Mutations in the CD19 gene suggesting irreversible loss of its surface expression are identified in the majority of analyzed cases of CD19– relapse in two clinical trials of pediatric ALL CD19 CAR T therapy: https://t.co/3zHzC6n1wK #immunotherapy https://t
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @ContinuumAEP: #NatureMedicine Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia https://t.co/u…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @RandiMHernandez: And a juicy tidbit from the associated editorial (in my head I immediately thought of a 2-car garage): "Taken togethe…
genetic mutations at the time of CD19– relapse to chimeric antigen receptor (CAR) therapy https://t.co/ZcC6pQBxjR
RT @AndyBiotech: Two new papers out in @NatureMedicine on CD19 CAR-T relapse and resistance mechanisms Penn's infamous CAR-B case https:/…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @FJCarmonas: A recent paper in @NatureMedicine reports an extremely rare case of resistance to #CARTcell therapy in a #leukemia patient…
RT @immuno_stuff: Online now @NatureMedicine: resistance to CAR-T cell #Immunotherapy: https://t.co/ptWMRc7U7B & https://t.co/EUOZmG2dTC #l…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
The minute you think you had a handle on human immunology, this happens.
RT @Eslamkatab90: Two important cases that showed early resistance to CD19 CAR T cells https://t.co/lUqC2xT27i
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
#NatureMedicine Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia https://t.co/uj5mo1UKkY
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @immuno_stuff: Online now @NatureMedicine: resistance to CAR-T cell #Immunotherapy: https://t.co/ptWMRc7U7B & https://t.co/EUOZmG2dTC #l…
RT @immuno_stuff: Online now @NatureMedicine: resistance to CAR-T cell #Immunotherapy: https://t.co/ptWMRc7U7B & https://t.co/EUOZmG2dTC #l…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
Online now @NatureMedicine: resistance to CAR-T cell #Immunotherapy: https://t.co/ptWMRc7U7B & https://t.co/EUOZmG2dTC #leukemia @NovartisOncCT @PennMedicine
RT @FJCarmonas: A recent paper in @NatureMedicine reports an extremely rare case of resistance to #CARTcell therapy in a #leukemia patient…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @BiotechMania: CAR-T細胞療法後の再発・耐性獲得メカニズムの論文が出ています。 https://t.co/nEmSCBZHcb
RT @LabWaggoner: Mutations driving CAR escape. https://t.co/1WeX7ozYjX
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @AndyBiotech: Two new papers out in @NatureMedicine on CD19 CAR-T relapse and resistance mechanisms Penn's infamous CAR-B case https:/…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @AndyBiotech: Two new papers out in @NatureMedicine on CD19 CAR-T relapse and resistance mechanisms Penn's infamous CAR-B case https:/…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @AmadeoWals: ..pero... esperemos que las prisas no hagan una burbuja de la inmunoterapia que nos estalle como otras tantas veces ocurre.…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @FJCarmonas: A recent paper in @NatureMedicine reports an extremely rare case of resistance to #CARTcell therapy in a #leukemia patient…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…
RT @EricTopol: On the day when @NobelPrize recognizes #cancer immunotherapy, new insights about resistance to chimeric antigen receptor T c…